AVH – ReCell Reduces Long-Term Scarring and Itching Outcomes in Pediatric Burns Treatment

/in

Northridge, CA and Cambridge, UK, 6 May 2016 – Link here.

Read more

Rex Bionics inks US Army deal to test robot exoskeletons with amputees

/in

https://www.stuff.co.nz/business/better-business/78700698/Rex-Bionics-inks-US-Army-deal-to-test-robot-exoskeletons-with-amputees Auckland robotics company Rex Bionics has signed a deal with the United States Army to help amputee soldiers get back on their feet. The special agreement means the firm, which develops robotic suits and legs, will be able to test out its developing “Rex Suit” technology on hundreds of maimed veterans Rex Bionics has spent many years and millions […]

Read more

AmpliPhi Biosciences Reports First Quarter 2016 Financial Results and Provides Corporate Update

/in

SAN DIEGO, May 12, 2016 – Link here. AmpliPhi Biosciences Corporation (NYSEMKT: APHB), a global leader in the development of bacteriophage-based antibacterial therapies to treat drug-resistant infections, today announced its financial results for the first quarter ended March 31, 2016. “We have made significant progress in 2016, effectively executing on our clinical development and business […]

Read more

Nexvet Reports Financial Results for Third Quarter of Fiscal Year 2016

/in

DUBLIN, Ireland, May 12, 2016 (GLOBE NEWSWIRE) — Link here. Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced its financial results for the three and nine-month periods ended March 31, 2016. Recent company highlights include: Advanced clinical development and regulatory preparations for ranevetmab (NV-01), for the control of pain associated with osteoarthritis in dogs […]

Read more

Avita Medical’s ReCell Technology Demonstrated at Vitiligo Conferences in China

/in

Northridge, CA, USA, Perth, Australia and Cambridge, United Kingdom, 3 May 2016 – Link here.

Read more

Nexvet and Zenoaq Announce PD-1 mAb Candidate for Canine Cancer & USDA Regulatory Jurisdiction Confirmed

/in

DUBLIN, Ireland, May 02, 2016 (GLOBE NEWSWIRE) – Link here – Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, and Zenoaq (Nippon Zenyaku Kogyo Co., Ltd.), a leading Japanese animal health company, announced today their research and development collaboration has yielded fully caninized, or ‘100% dog’, monoclonal antibodies (mAbs) that bind and potently inhibit the immuno-oncology […]

Read more